HDFC Innovation Fund Regular-Growth
Mid CapEquity: Thematic-InnovationVery High Risk
PaisaSmart ratingNot rated yet
Why this rating
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
Our score weighs long-term performance, risk and consistency — not just past returns.
Returns
As of 21 Sep 2026
1W
+0.67%
1M
+0.26%
3M
+10.94%
6M
+26.59%
9M
+16.39%
1Y
+13.65%
Since launch
+16.32%
Portfolio
As of 31 Aug 2026
Market-cap split
Large cap48.66%Mid cap25.99%Small cap25.35%
P/E
50.02
P/B
6.14
Style
Growth
Sector allocation
Healthcare21.29%
Services19.27%
Capital Goods17.09%
Automobile8.40%
Technology7.83%
Financial7.60%
Energy6.35%
Chemicals3.78%
Holdings (77)
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| Eternal Ltd. | 9.63% | ₹306.97 Cr | 93,55,992 |
| Bajaj Finance Ltd. | 4.38% | ₹139.52 Cr | 13,20,000 |
| Divi's Laboratories Ltd. | 4.08% | ₹130.19 Cr | 1,37,519 |
| Rubicon Research Ltd. | 3.57% | ₹113.72 Cr | 6,24,949 |
| Mahindra & Mahindra Ltd. | 3.41% | ₹108.73 Cr | 3,31,285 |
| PB Fintech Ltd. | 3.32% | ₹106.02 Cr | 5,65,432 |
| Bharat Electronics Ltd. | 3.29% | ₹104.81 Cr | 25,29,000 |
| Hindustan Aeronautics Ltd. | 2.77% | ₹88.34 Cr | 1,83,975 |
| Sun Pharmaceutical Industries Ltd. | 2.75% | ₹87.56 Cr | 4,41,150 |
| Lenskart Solutions Ltd. | 2.72% | ₹86.66 Cr | 13,08,250 |
Fund details
In brief
Capital appreciation over long term, to invest in equity and equity related instruments of companies that are adopting innovative themes and strategies.
Investment objective
The scheme seeks to generate long-term capital appreciation / income by investing in companies that are adopting innovative themes and strategies. There is no assurance that the investment objective of the scheme will be achieved.
Exit load
Exit load of 1%, if redeemed within 1 month.
Fund type
Open-ended
Min lumpsum
₹100
Min withdrawal
₹100
Lock-in
None
SIP
Available
SWP
Available
STP
Available
Purchase cut-off
15:00